Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 13/20 | 0.91 |
| ▸ | CA1 | P00915 | 13/20 | 0.91 |
| ▸ | CA9 | Q16790 | 13/20 | 0.91 |
| ▸ | CA2 | P00918 | 11/20 | 0.91 |
| ▸ | MGLL | Q99685 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | EHMT2 | Q96KQ7 | 2/20 | 0.50 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2379653 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL2380360 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL4389382 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL2378770 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL2382500 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL4513484 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL4398000 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL2475352 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL968412 | 0.98 | CA12 (0.87) | CA12CA1CA9CA2MGLL | |
| SCHEMBL7117660 | 0.98 | CA12 (0.87) | CA12CA1CA9CA2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4039879-A1 | WIRE ROPE | Toyoflex Corporation (JP) | 2022-08-10 | — | — | EP | disclosed |
| US-20220186433-A1 | WIRE ROPE | TOYOFLEX CORPORATION (JP) | 2022-06-16 | — | — | US | disclosed |
| US-8207098-B2 | Lubricant additive, lubricant composition and grease composition | YAMANASHI UNIVERSITY (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20090239773-A1 | LUBRICANT ADDITIVE, LUBRICANT COMPOSITION AND GREASE COMPOSITION | YAMANASHI UNIVERSITY (JP) | 2009-09-24 | — | — | US | disclosed |
| EP-1772512-A2 | Sliding structure and sliding method | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-20070078067-A1 | Sliding structure and sliding method | TOYOTA JIDOSHA KABUSHIKI KAISHA | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239773-A1 | LUBRICANT ADDITIVE, LUBRICANT COMPOSITION AND GREASE COMPOSITION | GRN, GRIA1, GRIK5 | CA12 4407/4885CA1 2983/4885CA9 3776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.